These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27811370)
1. IL-10 and PRKDC polymorphisms are associated with glioma patient survival. Hu M; Du J; Cui L; Huang T; Guo X; Zhao Y; Ma X; Jin T; Li G; Song J Oncotarget; 2016 Dec; 7(49):80680-80687. PubMed ID: 27811370 [TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the IL4R gene and clinical features are associated with glioma prognosis: Analyses of case-cohort studies. Jin TB; Du S; Zhu XK; Li G; Ouyang Y; He N; Zhang Z; Zhang Y; Kang L; Yuan D Medicine (Baltimore); 2016 Aug; 95(31):e4231. PubMed ID: 27495027 [TBL] [Abstract][Full Text] [Related]
3. The effects of gene polymorphisms on glioma prognosis. Cui Y; Li G; Yan M; Li J; Jin T; Li S; Mu S J Gene Med; 2017 Nov; 19(11):345-352. PubMed ID: 28985021 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer. Zhang X; Wang Y; Ning Y Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181 [TBL] [Abstract][Full Text] [Related]
5. Effect of epidermal growth factor receptor gene polymorphisms on prognosis in glioma patients. Li B; Zhao W; Li J; Yan M; Xie Z; Zhu Y; Chen C; Jin T Oncotarget; 2016 Sep; 7(39):63054-63064. PubMed ID: 27437777 [TBL] [Abstract][Full Text] [Related]
6. The polymorphisms (rs3213801 and rs5744533) of DNA polymerase kappa gene are not related with glioma risk and prognosis: A case-control study. Wu Y; Zhou L; Deng Y; Li N; Yang P; Dong S; Yang S; Zheng Y; Yao L; Zhang M; Zhai Z; Dai Z; Wu Y Cancer Med; 2019 Dec; 8(17):7446-7453. PubMed ID: 31595696 [TBL] [Abstract][Full Text] [Related]
7. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma. Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539 [TBL] [Abstract][Full Text] [Related]
8. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas. Leeper HE; Caron AA; Decker PA; Jenkins RB; Lachance DH; Giannini C Oncotarget; 2015 Oct; 6(30):30295-305. PubMed ID: 26210286 [TBL] [Abstract][Full Text] [Related]
9. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas. Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma. Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187 [TBL] [Abstract][Full Text] [Related]
11. High CHI3L1 expression is associated with glioma patient survival. Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858 [TBL] [Abstract][Full Text] [Related]
12. Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis. Xavier-Magalhães A; Oliveira AI; de Castro JV; Pojo M; Gonçalves CS; Lourenço T; Viana-Pereira M; Costa S; Linhares P; Vaz R; Nabiço R; Amorim J; Pinto AA; Reis RM; Costa BM J Neurooncol; 2017 Mar; 132(1):27-34. PubMed ID: 28083786 [TBL] [Abstract][Full Text] [Related]
13. Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma. Ryall S; Krishnatry R; Arnoldo A; Buczkowicz P; Mistry M; Siddaway R; Ling C; Pajovic S; Yu M; Rubin JB; Hukin J; Steinbok P; Bartels U; Bouffet E; Tabori U; Hawkins C Acta Neuropathol Commun; 2016 Aug; 4(1):93. PubMed ID: 27577993 [TBL] [Abstract][Full Text] [Related]
14. FGF2 as a potential prognostic biomarker for proneural glioma patients. Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma. Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767 [TBL] [Abstract][Full Text] [Related]
16. Impact of TGF-β1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosis. Vieira de Castro J; Gonçalves CS; Costa S; Linhares P; Vaz R; Nabiço R; Amorim J; Viana-Pereira M; Reis RM; Costa BM Tumour Biol; 2015 Aug; 36(8):6525-32. PubMed ID: 25813152 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma. Scheurer ME; Amirian E; Cao Y; Gilbert MR; Aldape KD; Kornguth DG; El-Zein R; Bondy ML Clin Cancer Res; 2008 Oct; 14(20):6640-6. PubMed ID: 18927306 [TBL] [Abstract][Full Text] [Related]
18. Impact of ANXA5 polymorphisms on glioma risk and patient prognosis. Guo X; Song J; Zhao J; Wang B; Yang Z; Sun P; Hu M J Neurooncol; 2019 Mar; 142(1):11-26. PubMed ID: 30536196 [TBL] [Abstract][Full Text] [Related]
19. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas. Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811 [TBL] [Abstract][Full Text] [Related]
20. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma. Li B; Wang Y; Li S; He H; Sun F; Wang C; Lu Y; Wang X; Tao B Int J Clin Exp Pathol; 2015; 8(6):7016-21. PubMed ID: 26261592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]